Osteopontin expression in human crescentic glomerulonephritis

Kidney International

Volumn 57, Issue 1, 2000, Pages 105-116

  Hudkins, Kelly L ^a   Giachelli, Cecilia M ^a   Eitner, Frank ^a   Couser, William G ^a   Johnson, Richard J ^a   Alpers, Charles E ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

Anti glomerular basement membrane glomerulonephritis; Crescentic lesion; Inflammation; Macrophages; Monocytes; Renal injury

Indexed keywords

IMMUNOGLOBULIN A; OSTEOPONTIN;

ARTICLE; CONTROLLED STUDY; GLOMERULONEPHRITIS; GLOMERULUS BASEMENT MEMBRANE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFLAMMATION; KIDNEY BIOPSY; KIDNEY INJURY; LUPUS ERYTHEMATOSUS NEPHRITIS; MONOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033997741     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00813.x     Document Type: Article

References (59)

1. 1. Brown LF, Berse B, Van De Water L, Papadopoulos-Sergiou A, Perruzzi CA, Manseau EJ, Dvorak HF, Senger DR: Expression and distribution of osteopontin in human tissues: Widespread association with luminal epithelial surfaces. Mol Biol Cell 3:1169-1180, 1992
2. 2. Butler WT: The nature and significance of osteopontin. Connect Tissue Res 23:123-136, 1989
3. 3. Giachelli C, Bae N, Lombardi D, Majesky M, Schwartz S: Molecular cloning and characterization of 2B7, a rat mRNA which distinguishes smooth muscle cell phenotypes in vitro and is identical to osteopontin (secreted phosphoprotein I, 2aR). Biochem Biophys Res Commun 177:867-873, 1991
4. 4. Giachelli CM, Liaw L, Murry CE, Schwartz SM, Almeida M: Osteopontin expression in cardiovascular diseases. Ann NY Acad Sci 760:109-126, 1995
5. 5. Murry CE, Giachelli CM, Schwartz SM, Vracko R: Macrophages express osteopontin during repair of myocardial necrosis. Am J Pathol 145:1450-1462, 1994
6. 6. McKee MD, Nanci A: Secretion of osteopontin by macrophages and its accumulation at tissue surfaces during wound healing in mineralized tissues: A potential requirement for macrophage adhesion and phagocytosis. Anat Rec 245:394-409, 1996
7. 7. Liaw L, Almeida M, Hart CE, Schwartz SM, Giachelli CM: Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells in vitro. Circ Res 74:214-224, 1994
8. 8. Giachelli CM, Lombardi D, Johnson RJ, Murry CE, Almeida M: Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo. Am J Pathol 152:353-358, 1998
9. 9. Singh RP, Patarca R, Schwartz J, Singh P, Cantor H: Definition of a specific interaction between the early T lymphocyte activation 1 (Eta-1) protein and murine macrophages in vitro and its effect upon macrophages in vivo. J Exp Med 171:1931-1942, 1990
10. 10. Sibalic V, Fan X, Loffing J, Wuthrich RP: Upregulated renal tubular CD44, hyaluronan, and osteopontin in kdkd mice with interstitial nephritis. Nephrol Dial Transplant 12:1344-1353, 1997
11. 11. Pichler R, Giachelli CM, Lombardi D, Pippin J, Gordon K, Alpers CE, Schwartz SM, Johnson RJ: Tubulointerstitial disease in glomerulonephritis: Potential role of osteopontin (uropontin). Am J Pathol 144:915-926, 1994
12. 12. Pichler RH, Franceschini N, Young BA, Hugo C, Andoh TF, Burdmann EA, Shankland SJ, Alpers CE, Bennett WM, Couser WG, Johnson RJ: Pathogenesis of cyclosporine nephropathy: Roles of angiotensin II and osteopontin. J Am Soc Nephrol 6:1186-1196, 1995
13. 13. Ophascharoensuk V, Giachelli CM, Liaw L, Gordon K, Schmidt R, Alpers CE, Shankland SJ, Couser WJ, Johnson RJ: Obstructive neuropathy in the mouse: Role of osteopontin in interstitial fibrosis and apoptosis. Kidney Int 56:571-580, 1999
14. 14. Giachelli CM, Pichler R, Lombardi D, Denhardt DT, Alpers CE, Schwartz SM, Johnson RJ: Osteopontin expression in angiotensin II-induced tubulointerstitial nephritis. Kidney Int 45:515-524, 1994
15. 15. Magil AB, Pichler RH, Johnson RJ: Osteopontin in chronic puromycin aminonucleoside nephrosis. J Am Soc Nephrol 8:1383-1390, 1997
16. 3 integrin-induced endothelial cell survival. J Cell Biol 141:1083-1093, 1998
17. 17. Pichler R, Giachelli C, Young B, Alpers CE, Couser WG, Johnson RJ: The pathogenesis of tubulointerstitial disease associated with glomerulonephritis: The glomerular cytokine theory. Miner Electrolyte Metab 21:317-327, 1995
18. 18. Eddy AA, Giachelli CM: Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein-overload proteinuria. Kidney Int 47:1546-1557, 1995
19. 19. Kleinman JG, Worcester EM, Beshensky AM, Sheridan AM, Bonventre JV, Brown D: Upregulation of osteopontin expression by ischemia in rat kidney. Ann NY Acad Sci 760:321-323, 1995
20. 20. Lan HY, Yu XQ, Yang N, Nikolic-Paterson DJ, Mu W, Pichler R, Johnson RJ, Atkins RC: De novo glomerular osteopontin expression in rat crescentic glomerulonephritis. Kidney Int 53:136-145, 1998
21. 21. Yu XQ, Nikolic-Paterson DJ, Mu W, Giachelli CM, Atkins RC, Johnson RJ, Lan HY: A functional role for osteopontin in experimental crescentic glomerulonephritis in the rat. Proc Assoc Am Physicians 110:50-64, 1998
22. 22. Fisher LW, Hawkins GR, Tuross N, Termine JD: Purification and partial characterization of small proteoglycans I and II, bone sialoproteins I and II, and osteonectin from the mineral compartment of developing human bone. J Biol Chem 262:9702-9708, 1987
23. 23. Giachelli CM, Bae N, Almeida M, Denhardt DT, Alpers CE, Schwartz SM: Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J Clin Invest 92:1686-1696, 1993
24. 24. O'Brien ER, Garvin MR, Stewart DK, Hinohara T, Simpson JB, Schwartz SM, Giachelli CM: Osteopontin is synthesized by macrophage, smooth muscle, and endothelial cells in primary and restenotic human coronary atherosclerotic plaques. Arterioscler Thromb 14:1648-1656, 1994
25. 25. Hudkins KL, Giachelli CM, Cui Y, Couser WG, Johnson RJ, Alpers CE: Osteopontin expression in fetal and mature human kidney. J Am Soc Nephrol 10:444-457, 1999
26. 26. Falini B, Flenghi L, Pileri S, Gambacorta M, Bigerna B, Durkop H, Eitelbach F, Thiele J, Pacini R, Cavaliere A, Martelli M, Cardarelli N, Sabattini E, Poggi S, Stein H: PG-M1: A new monoclonal antibody directed against a fixative-resistant epitope on the macrophage-restricted form of the CD68 molecule. Am J Pathol 142:1359-1372, 1993
27. 27. Gown AM, Tsukada T, Ross R: Human atherosclerosis. II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. Am J Pathol 125:191-207, 1986
28. 28. Skalli O, Ropraz P, Trzeciak A, Benzonana G, Gillessen D, Gabbiani G: A monoclonal antibody against alpha-smooth muscle actin: A new probe for smooth muscle differentiation. J Cell Biol 103:2787-2796, 1986
29. 29. Alpers CE, Hudkins KL, Gown AM, Johnson RJ: Enhanced expression of "muscle-specific" actin in glomerulonephritis. Kidney Int 41:1134-1142, 1992
30. 30. Johnson RJ, Iida H, Alpers CE, Majesky MW, Schwartz SM, Pritzi P, Gordon K, Gown AM: Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis: Alpha-smooth muscle actin is a marker of mesangial cell proliferation. J Clin Invest 87:847-858, 1991
31. 31. Combs HL, Shankland SJ, Setzer SV, Hudkins KL, Alpers CE: Expression of the cyclin kinase inhibitor, p27kip1, in developing and mature human kidney. Kidney Int 53:892-896, 1998
32. 32. Mundlos S, Pelletier J, Darveau A, Bachmann M, Winterpacht A, Zabel B: Nuclear localization of the protein encoded by the Wilms' tumor gene WT1 in embryonic and adult tissues. Development 119:1329-1341, 1993
33. 33. Mason DY, Krissansen GW, Davey FR, Crumpton MJ, Gatter KC: Antisera against epitopes resistant to denaturation on T3 (CD3) antigen can detect reactive and neoplastic T cells in paraffin embedded tissue biopsy specimens. J Clin Pathol 41:121-127, 1988
34. 34. Alpers CE, Hudkins KL, Davis CL, Marsh CL, Riches W, McCarty JM, Benjamin CD, Carlos TM, Harlan JM, Lobb R: Expression of vascular cell adhesion molecule-1 in kidney allograft rejection. Kidney Int 44:805-816, 1993
35. 35. Seron D, Cameron JS, Haskard DO: Expression of VCAM-1 in the normal and diseased kidney. Nephrol Dial Transplant 6:917-922, 1991
36. 36. Cooper D, Schermer A, Pruss R, Sun TT: The use of aIF, AE1, and AE3 monoclonal antibodies for the identification and classification of mammalian epithelial keratins. Differentiation 28:30-35, 1984
37. 37. Weiss RA, Eichner R, Sun TT: Monoclonal antibody analysis of keratin expression in epidermal diseases: A 48- and 56-kdalton keratin as molecular markers for hyperproliferative keratinocytes. J Cell Biol 98:1397-1406, 1984
38. 38. Magil AB: Histogenesis of glomerular crescents: Immunohisto-chemical demonstration of cytokeratin in crescent cells. Am J Pathol 120:222-229, 1985
39. 39. Young MF, Kerr JM, Termine JD, Wewer UM, Wang MG, McBride OW, Fisher LW: cDna cloning, mRna distribution and heterogeneity, chromosomal location, and Rflp analysis of human osteopontin (Opn). Genomics 7:491-502, 1990
40. 40. Alpers CE, Hudkins KL, Ferguson M, Johnson RJ, Rutledge JC: Platelet-derived growth factor A-chain expression in developing and mature human kidneys and in Wilms' tumor. Kidney Int 48:146-154, 1995
41. 41. Couser WG: Rapidly progressive glomerulonephritis: Classification, pathogenetic mechanisms, and therapy. Am J Kidney Dis 11:449-464, 1988
42. 42. Huang XR, Holdsworth SR, Tipping PG: Evidence for delayed-type hypersensitivity mechanisms in glomerular crescent formation. Kidney Int 46:69-78, 1994
43. 43. Kawasaki K, Yaoita E, Yamamoto T, Kihara I: Depletion of CD8 positive cells in nephrotoxic serum nephritis of WKY rats. Kidney Int 41:1517-1526, 1992
44. 44. Tipping PG, Huang XR, Van Qi MGY, Tang WW: Crescentic glomerulonephritis in CD4- and CD8-deficient mice. Requirement for CD4 but not CD8 cells. Am J Pathol 152:1541-1548, 1998
45. 45. Bolton WK, Innes DJ Jr, Sturgill BC, Kaiser DL: T-cells and macrophages in rapidly progressive glomerulonephritis: Clinico-pathologic correlations. Kidney Int 32:869-876, 1987
46. 46. Hancock WW, Atkins RC: Cellular composition of crescents in human rapidly progressive glomerulonephritis identified using monoclonal antibodies. Am J Nephrol 4:177-181, 1984
47. 47. Hooke DH, Gee DC, Atkins RC: Leukocyte analysis using monoclonal antibodies in human glomerulonephritis. Kidney Int 31:964-972, 1987
48. 48. Stachura I, Si L, Whiteside TL: Mononuclear-cell subsets in human idiopathic crescentic glomerulonephritis (ICGN): Analysis in tissue sections with monoclonal antibodies. J Clin Immunol 4:202-208, 1984
49. 49. Miyazaki Y, Setoguchi M, Yoshida S, Higuchi Y, Akizuki S, Yamamoto S: The mouse osteopontin gene: Expression in monocytic lineages and complete nucleotide sequence. J Biol Chem 265:14432-14438, 1990
50. 50. Miyazaki Y, Tashiro T, Higuchi Y, Setoguchi M, Yamamoto S, Nagai H, Nasu M, Vassalli P: Expression of osteopontin in a macrophage cell line and in transgenic mice with pulmonary fibrosis resulting from the lung expression of a tumor necrosis factor-alpha transgene. Ann NY Acad Sci 760:334-341, 1995
51. 51. Denhardt DT, Guo X: Osteopontin: A protein with diverse functions. FASEB J 7:1475-1482, 1993
52. 52. Diamond JR, Kees-Folts D, Ricardo SD, Pruznak A, Eufemio M: Early and persistent up-regulated expression of renal cortical osteopontin in experimental hydronephrosis. Am J Pathol 146:1455-1466, 1995
53. 53. Lopez CA, Hoyer JR, Wilson PD, Waterhouse P, Denhardt DT: Heterogeneity of osteopontin expression among nephrons in mouse kidneys and enhanced expression in sclerotic glomeruli. Lab Invest 69:355-363, 1993
54. 54. Hirota S, Imakita M, Kohri K, Ito A, Morii E, Adachi S, Kim HM, Kitamura Y, Yutani C, Nomura S: Expression of osteopontin messenger RNA by macrophages in atherosclerotic plaques: A possible association with calcification. Am J Pathol 143:1003-1008, 1993
55. 55. Atkins K, Berry JE, Zhang WZ, Harris JF, Chambers AF, Simpson RU, Somerman MJ: Coordinate expression of OPN and associated receptors during monocyte/macrophage differentiation of HL-60 cells. J Cell Physiol 175:229-237, 1998
56. 56. Liaw L, Skinner MP, Raines EW, Ross R, Cheresh DA, Schwartz SM, Giachelli CM: The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins: Role of α/β 3 in smooth muscle cell migration to osteopontin in vitro. J Clin Invest 95:713-724, 1995
57. 57. Ghosh S, May MJ, Kopp EB: NF-kappa B and Rel proteins: Evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16:225-260, 1998
58. 58. Tseng SC, Jarvinen MJ, Nelson WG, Huang JW, Woodcock-Mitchell J, Sun TT: Correlation of specific keratins with different types of epithelial differentiation: Monoclonal antibody studies. Cell 30:361-372, 1982
59. 59. Erber WN, Pinching AJ, Mason DY: Immunocytochemical detection of T and B cell populations in routine blood smears. Lancet 1:1042-1046, 1984